This pilot clinical trial studies the changes in dynamic perfusion computed tomography images before, during, and after stereotactic body radiation therapy in patients with stage I-II non-small cell lung cancer that has not spread to other parts of the body. Diagnostic imaging procedures, such as dynamic perfusion computed tomography, measure blood flow through tumors. Stereotactic body radiation therapy is a specialized radiation therapy that sends x-rays directly to the tumor using smaller doses over several days and may cause less damage to normal tissue. Giving dynamic perfusion computed tomography images before, during, and after stereotactic body radiation therapy may help better understand how radiation therapy works to stop tumor growth in patients with non-small cell lung cancer.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in blood flow (mL/min/100 g) as measured on perfusion CT
Timeframe: Baseline to up to 3 months post SBRT
Change in blood volume (mL/100 g) as measured on perfusion CT
Timeframe: Baseline to up to 3 months post SBRT
Change in mean transit time (seconds) as measured on perfusion CT
Timeframe: Baseline to up to 3 months post SBRT
Change in permeability (mL/min/100 g) as measured on perfusion CT
Timeframe: Baseline to up to 3 months post SBRT